Lung Cancer Trial, Recruiting NCT07232433 Sponsor: Ruijin Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07232433
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 or older
  • People whose cancer has been confirmed either through a tissue sample test or by a team of medical specialists reviewing their case together
  • People with a single ground-glass nodule (a type of lung spot) measuring between 6 and 30 mm, or multiple ground-glass nodules each measuring between 6 and 30 mm, with no more than 3 nodules identified by the specialist team as needing treatment
  • People for whom keyhole lung surgery (called VATS) is not considered suitable by their doctors, or who have chosen not to have it
  • People for whom radiation therapy or a targeted radiation treatment called SBRT is not considered suitable, or who have chosen not to have it
  • People who are generally well and able to carry out daily activities with little to no limitation, as measured by a standard medical scale (ECOG score of 0 or 1)
  • People who are willing to follow the trial requirements and have signed a written consent form agreeing to take part

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with serious heart, lung, liver, or kidney problems that would make general anaesthesia unsafe
  • People for whom bronchoscopy (a camera procedure into the airways) or a CT-guided needle procedure through the skin would not be safe or appropriate
  • People where at least one of the target nodules carries a high risk for a needle procedure through the skin, or where no safe pathway to reach the nodule has been identified during pre-procedure planning
  • People with a very low platelet count (below 50 × 10⁹/L), or a bleeding or clotting problem that cannot be corrected (confirm specific blood test thresholds with trial site)
  • People who are already taking part in another interventional clinical trial, or who are expected to need cancer treatments beyond what this trial covers during the study period
  • People whom the trial doctor considers unsuitable for any other medical reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 021-021-64370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
21 November 2025
Est. completion
1 October 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

2-Year Local Recurrence Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov